Year: 2011
Type: review
Abstract: There is a widespread acceptance in the literaturethat plasma nonesterified fatty acids (NEFA),also called free fatty acids (FFA), can mediatemany adverse metabolic effects, most notably insulin resistance. Elevated NEFA concentrations in obe-sity are thought to arise from an increased adipose tissue mass. It is also argued that the process of fatty acid mo-bilization from adipose tissue, normally suppressed by in-sulin, itself becomes insulin resistant—thus, lipolysis is further increased, potentially leading to a vicious cycle. Although we have also accepted this model for many years (1,2), recently there has been a steady accumulation of data, both in the literature and from our own research, that has forced us to realize that this simple story is not always true. Here we review the background to the idea of “fatty acids as metabolic villains, ” together with data from the literature and from our own studies, which tend to show another side to the fatty acids/insulin resistance story. We will first examine the relationship between systemic concentrations of NEFA and obesity/insulin resistance and then study adipose tissue in the obese state with regard to its adaptation for NEFA release. FATTY ACIDS AND METABOLIC PHYSIOLOGY NEFA circulate in the plasma bound to plasma albumin. Their function was largely elucidated in the 1950s through
Source: Diabetes
DOI: 10.2337/db11-0425
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2152688545
